The main thrust of this project is to develop experimental approaches to the study of leukemia founded on immunogenetic principles that may be helpful in achieving progress toward the control or elimination of leukemias in man. Four interrelated systems will be investigated: (1) with respect to the role of H-2 linked immune response genes in control of neoplastic cell growth in AKR leukemogenesis we shall study (a) the role of suppression, (b) the role and response to a 58K protein on the cell surface of some AKR tumor cells (BW5147) and (c) the possibility of vaccination against spontaneous leukemia. (2) With respect to the existence of a transformation-sensitive lymphocyte population (TSL) our goal is to determine (a) whether such a population is identifiable by a new cell surface marker, Ly 9.2 (or its counterpart Ly 9.1) (b) the pathway of differentiatin of Ly 9.2 positive cells, (c) and the outcome of elimination of Ly 9.2 positive cells on susceptibility to leukemia. In addition, (d) we seek to chemically characterize Ly 9.1 or 2 antigens and determine their genetic and chemical polymorphism. (3) With respect to question of a viral etiology for x-irradiation-induced leukemia we wish to further determine the role of H-2D linked genes in (a) alterations of bone-marrow thymocyte differentiation pathways and (b) in immune surveillance against neoplasia. (4) With regard to the immunology of resistance to RadLV-induced neoplasia we wish to (a) characterize the effector cells involved (b) determine the role of suppression during the disease, and (c) in addition, a provocative question raised by our observations regarding effects of RadLV infection on H-2 antigen expression is the role of viral integration at or near H-2D gene(s). To this end, we shall examine amino acid homologies between H-2D antigens and viral proteins, particularly p12.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA022247-09
Application #
3165789
Study Section
Immunobiology Study Section (IMB)
Project Start
1977-08-01
Project End
1989-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
9
Fiscal Year
1986
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Tseng, Jen-Chieh; Zanzonico, Pat B; Levin, Brandi et al. (2006) Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 47:1136-43
Hurtado, Alicia; Tseng, Jen-Chieh; Meruelo, Daniel (2006) Gene therapy that safely targets and kills tumor cells throughout the body. Rejuvenation Res 9:36-44
Hurtado, Alicia; Tseng, Jen-Chieh; Boivin, Christopher et al. (2005) Identification of amino acids of Sindbis virus E2 protein involved in targeting tumor metastases in vivo. Mol Ther 12:813-23
Tseng, Jen-Chieh; Hurtado, Alicia; Yee, Herman et al. (2004) Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 64:6684-92
Tseng, Jen-Chieh; Levin, Brandi; Hurtado, Alicia et al. (2004) Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22:70-7
Tseng, Jen-Chieh; Levin, Brandi; Hirano, Tadamichi et al. (2002) In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst 94:1790-802
Choi, Jung W; Pampeno, Christine; Vukmanovic, Stanislav et al. (2002) Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol 26:575-88
Pampeno, C L; Vallerie, A M; Choi, J et al. (2001) Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol 20:141-8
Ishizu, A; Sawai, K; Ikeda, H et al. (2000) Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Int Immunol 12:161-8
Yu, A; Choi, J; Ohno, K et al. (2000) Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol 19:383-8

Showing the most recent 10 out of 43 publications